Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 136

1.

Optimized Lysis-Extraction Method Combined With IS6110-Amplification for Detection of Mycobacterium tuberculosis in Paucibacillary Sputum Specimens.

Kolia-Diafouka P, Godreuil S, Bourdin A, Carrère-Kremer S, Kremer L, Van de Perre P, Tuaillon E.

Front Microbiol. 2018 Sep 25;9:2224. doi: 10.3389/fmicb.2018.02224. eCollection 2018.

2.

Matching-Adjusted Indirect Comparison of Benralizumab versus Interleukin-5 Inhibitors: Systematic Review.

Bourdin A, Husereau D, Molinari N, Golam S, Siddiqui MK, Lindner L, Xu X.

Eur Respir J. 2018 Oct 11. pii: 1801393. doi: 10.1183/13993003.01393-2018. [Epub ahead of print]

PMID:
30309978
3.

Generation of the induced pluripotent stem cell line UHOMi001-A from a patient with mutations in CCDC40 gene causing Primary Ciliary Dyskinesia (PCD).

Ahmed E, Sansac C, Fieldes M, Bergougnoux A, Bourguignon C, Mianné J, Arnould C, Vachier I, Assou S, Bourdin A, De Vos J.

Stem Cell Res. 2018 Sep 28;33:15-19. doi: 10.1016/j.scr.2018.09.019. [Epub ahead of print]

4.

Induced Pluripotent Stem Cells for Primary Ciliary Dyskinesia Modeling and Personalized Medicine.

Mianné J, Ahmed E, Bourguignon C, Fieldes M, Vachier I, Bourdin A, Assou S, De Vos J.

Am J Respir Cell Mol Biol. 2018 Sep 19. doi: 10.1165/rcmb.2018-0213TR. [Epub ahead of print]

PMID:
30230352
5.

Cost-effectiveness of lung volume reduction coil treatment in patients with severe emphysema: results from the 2-year follow-up crossover REVOLENS study (REVOLENS-2 study).

Bulsei J, Leroy S, Perotin JM, Mal H, Marquette CH, Dutau H, Bourdin A, Vergnon JM, Pison C, Kessler R, Jounieaux V, Salaün M, Marceau A, Dukic S, Barbe C, Bonnaire M, Deslee G, Durand-Zaleski I; REVOLENS study group.

Respir Res. 2018 May 9;19(1):84. doi: 10.1186/s12931-018-0796-x.

6.

B cells response directed against Cut4 and CFP21 lipolytic enzymes in active and latent tuberculosis infections.

Rénier W, Bourdin A, Rubbo PA, Peries M, Dedieu L, Bendriss S, Kremer L, Canaan S, Terru D, Godreuil S, Nagot N, Van de Perre P, Tuaillon E.

PLoS One. 2018 Apr 30;13(4):e0196470. doi: 10.1371/journal.pone.0196470. eCollection 2018.

7.

Association between Rheumatoid Arthritis and Pulmonary Hypertension: Data from the French Pulmonary Hypertension Registry.

Montani D, Henry J, O'Connell C, Jaïs X, Cottin V, Launay D, Habib G, Bourdin A, Jevnikar M, Savale L, Rottat L, Simonneau G, Sitbon O, Humbert M, Allanore Y.

Respiration. 2018;95(4):244-250. doi: 10.1159/000485631. Epub 2018 Feb 28.

PMID:
29490304
8.

Impact of sacubitril-valsartan combination in patients with chronic heart failure and sleep apnoea syndrome: the ENTRESTO-SAS study design.

Jaffuel D, Molinari N, Berdague P, Pathak A, Galinier M, Dupuis M, Ricci JE, Mallet JP, Bourdin A, Roubille F.

ESC Heart Fail. 2018 Jun;5(3):222-230. doi: 10.1002/ehf2.12270. Epub 2018 Feb 22.

9.

Asthma, COPD, and overlap in a national cohort: ACO on a gradient.

Bourdin A, Suehs CM, Marin G, Vachier I, Matzner-Lober E, Chanez P, Molinari N; COBRA Consortium.

J Allergy Clin Immunol. 2018 Apr;141(4):1516-1518. doi: 10.1016/j.jaci.2017.11.049. Epub 2018 Jan 31. No abstract available.

PMID:
29355677
10.

Impact of psychological factors on the health-related quality of life of patients treated for pulmonary arterial hypertension.

Halimi L, Marin G, Molinari N, Gamez AS, Boissin C, Suehs CM, Vachier I, Bourdin A.

J Psychosom Res. 2018 Feb;105:45-51. doi: 10.1016/j.jpsychores.2017.12.003. Epub 2017 Dec 6.

PMID:
29332633
11.

RV function improvement following nitric oxide inhalation demonstrated by gated blood pool SPECT in a patient with primary pulmonary hypertension.

Ben Bouallègue F, Vauchot F, Bourdon A, Benkiran M, Boissin C, Charriot J, Bourdin A, Mariano-Goulart D.

J Nucl Cardiol. 2018 Jan 10. doi: 10.1007/s12350-017-1171-x. [Epub ahead of print] No abstract available.

PMID:
29322380
12.

Two-year follow-up after endobronchial coil treatment in emphysema: results from the REVOLENS study.

Deslée G, Leroy S, Perotin JM, Mal H, Dutau H, Bourdin A, Vergnon JM, Pison C, Kessler R, Jounieaux V, Salaün M, Marceau A, Dury S, Benzaquen J, Bonnaire M, Dukic S, Barbe C, Marquette CH; , on behalf of the REVOLENS Study Group13; REVOLENS Study Group.

Eur Respir J. 2017 Dec 21;50(6). pii: 1701740. doi: 10.1183/13993003.01740-2017. Print 2017 Dec. No abstract available.

PMID:
29269583
13.

Mortality: a neglected outcome in OCS-treated severe asthma.

Bourdin A, Molinari N, Vachier I, Pahus L, Suehs C, Chanez P.

Eur Respir J. 2017 Nov 30;50(5). pii: 1701486. doi: 10.1183/13993003.01486-2017. Print 2017 Nov. No abstract available.

PMID:
29191955
14.

The feasibility of a mandibular movement test as a screening tool for polysomnography candidates.

Rotty MC, Mallet JP, Borel JC, Suehs CM, Bourdin A, Molinari N, Jaffuel D.

Eur Respir J. 2017 Nov 30;50(5). pii: 1701076. doi: 10.1183/13993003.01076-2017. Print 2017 Nov. No abstract available.

PMID:
29191954
15.

Lung development, regeneration and plasticity: From disease physiopathology to drug design using induced pluripotent stem cells.

Ahmed E, Sansac C, Assou S, Gras D, Petit A, Vachier I, Chanez P, De Vos J, Bourdin A.

Pharmacol Ther. 2018 Mar;183:58-77. doi: 10.1016/j.pharmthera.2017.10.002. Epub 2017 Oct 4. Review.

PMID:
28987320
16.

Healthcare pathway and patients' expectations in pulmonary fibrosis.

Cottin V, Bourdin A, Crestani B, Prévot G, Guérin M, Bouquillon B.

ERJ Open Res. 2017 Apr 12;3(2). pii: 00134-2016. doi: 10.1183/23120541.00134-2016. eCollection 2017 Apr.

17.

Predictive factors for a one-year improvement in nontuberculous mycobacterial pulmonary disease: An 11-year retrospective and multicenter study.

Cadelis G, Ducrot R, Bourdin A, Rastogi N.

PLoS Negl Trop Dis. 2017 Aug 7;11(8):e0005841. doi: 10.1371/journal.pntd.0005841. eCollection 2017 Aug.

18.

Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension.

Boucly A, Weatherald J, Savale L, Jaïs X, Cottin V, Prevot G, Picard F, de Groote P, Jevnikar M, Bergot E, Chaouat A, Chabanne C, Bourdin A, Parent F, Montani D, Simonneau G, Humbert M, Sitbon O.

Eur Respir J. 2017 Aug 3;50(2). pii: 1700889. doi: 10.1183/13993003.00889-2017. Print 2017 Aug.

PMID:
28775050
19.

Management of acute exacerbations of chronic obstructive pulmonary disease (COPD). Guidelines from the Société de pneumologie de langue française (summary).

Jouneau S, Dres M, Guerder A, Bele N, Bellocq A, Bernady A, Berne G, Bourdin A, Brinchault G, Burgel PR, Carlier N, Chabot F, Chavaillon JM, Cittee J, Claessens YE, Delclaux B, Deslée G, Ferré A, Gacouin A, Girault C, Ghasarossian C, Gouilly P, Gut-Gobert C, Gonzalez-Bermejo J, Jebrak G, Le Guillou F, Léveiller G, Lorenzo A, Mal H, Molinari N, Morel H, Morel V, Noel F, Pégliasco H, Perotin JM, Piquet J, Pontier S, Rabbat A, Revest M, Reychler G, Stelianides S, Surpas P, Tattevin P, Roche N.

Rev Mal Respir. 2017 Apr;34(4):282-322. doi: 10.1016/j.rmr.2017.03.034. Epub 2017 May 25.

PMID:
28552256
20.

Oral Glucocorticoid-Sparing Effect of Benralizumab in Severe Asthma.

Nair P, Wenzel S, Rabe KF, Bourdin A, Lugogo NL, Kuna P, Barker P, Sproule S, Ponnarambil S, Goldman M; ZONDA Trial Investigators.

N Engl J Med. 2017 Jun 22;376(25):2448-2458. doi: 10.1056/NEJMoa1703501. Epub 2017 May 22.

21.

The HDAC inhibitor SAHA does not rescue CFTR membrane expression in Cystic Fibrosis.

Bergougnoux A, Petit A, Knabe L, Bribes E, Chiron R, De Sario A, Claustres M, Molinari N, Vachier I, Taulan-Cadars M, Bourdin A.

Int J Biochem Cell Biol. 2017 Jul;88:124-132. doi: 10.1016/j.biocel.2017.05.002. Epub 2017 May 3.

PMID:
28478266
22.

[What are the socio-economic consequences of acute COPD exacerbations?]

Bourdin A, Molinari N.

Rev Mal Respir. 2017 Apr;34(4):338-342. doi: 10.1016/j.rmr.2017.03.004. Epub 2017 May 2. French. No abstract available.

PMID:
28476415
23.

Epithelial ciliated beating cells essential for ex vivo ALI culture growth.

Gras D, Petit A, Charriot J, Knabe L, Alagha K, Gamez AS, Garulli C, Bourdin A, Chanez P, Molinari N, Vachier I.

BMC Pulm Med. 2017 May 3;17(1):80. doi: 10.1186/s12890-017-0423-5.

24.

Managing asthma in the era of biological therapies.

Bardin PG, Price D, Chanez P, Humbert M, Bourdin A.

Lancet Respir Med. 2017 May;5(5):376-378. doi: 10.1016/S2213-2600(17)30124-8. Epub 2017 Apr 24. Review. No abstract available.

PMID:
28463176
25.

Human bronchial epithelium orchestrates dendritic cell activation in severe asthma.

Gras D, Martinez-Anton A, Bourdin A, Garulli C, de Senneville L, Vachier I, Vitte J, Chanez P.

Eur Respir J. 2017 Mar 8;49(3). pii: 1602399. doi: 10.1183/13993003.02399-2016. Print 2017 Mar.

26.

Software-assisted Computed Tomography Quantification of Airway Remodeling in the Normal Aging Process.

Bommart S, Kovacsik H, Vachier I, Molinari N, Bourdin A.

Am J Respir Crit Care Med. 2017 Feb 15;195(4):540-541. doi: 10.1164/rccm.201610-2028LE. No abstract available.

PMID:
28199160
27.

Is the Muscle the Only Potential Target of Desipramine in Obstructive Sleep Apnea Syndrome?

Jaffuel D, Mallet JP, Dauvilliers Y, Bourdin A.

Am J Respir Crit Care Med. 2017 Jun 15;195(12):1677-1678. doi: 10.1164/rccm.201612-2506LE. No abstract available.

PMID:
28186828
28.

LIFE BEYOND LIFE - An Easy Way to Derive Lung Fibroblasts from Cadavers.

Colomb S, Bareil C, Baccino E, Berthet JP, Knabe L, Vachier I, Bourdin A.

J Forensic Sci. 2017 Sep;62(5):1339-1344. doi: 10.1111/1556-4029.13445. Epub 2017 Feb 10.

PMID:
28185266
29.

Efficacy of Whole-Lung Lavage in Pulmonary Alveolar Proteinosis: A Multicenter International Study of GELF.

Gay P, Wallaert B, Nowak S, Yserbyt J, Anevlavis S, Hermant C, Lovis A, Menard O, Maitre B, Vandemoortele T, Dutau H, Briault A, Bourdin A, Vergnon JM, Froudarakis ME; Groupe d''Endoscopie Thoracique de Langue Française.

Respiration. 2017;93(3):198-206. doi: 10.1159/000455179. Epub 2017 Jan 21.

30.

Club cell secretory protein serum concentration is a surrogate marker of small-airway involvement in asthmatic patients.

Bommart S, Marin G, Molinari N, Knabe L, Petit A, Chanez P, Gamez AS, Devautour C, Vachier I, Bourdin A.

J Allergy Clin Immunol. 2017 Aug;140(2):581-584. doi: 10.1016/j.jaci.2016.09.063. Epub 2017 Jan 17. No abstract available.

PMID:
28108336
31.

Opportunities to develop the professional role of community pharmacists in the care of patients with asthma: a cross-sectional study.

Watkins K, Bourdin A, Trevenen M, Murray K, Kendall PA, Schneider CR, Clifford R.

NPJ Prim Care Respir Med. 2016 Nov 24;26:16082. doi: 10.1038/npjpcrm.2016.82.

32.

Comparison of anti-interleukin-5 therapies in patients with severe asthma: global and indirect meta-analyses of randomized placebo-controlled trials.

Cabon Y, Molinari N, Marin G, Vachier I, Gamez AS, Chanez P, Bourdin A.

Clin Exp Allergy. 2017 Jan;47(1):129-138. doi: 10.1111/cea.12853. Epub 2016 Dec 8. Review.

PMID:
27859832
33.

Rising total costs and mortality rates associated with admissions due to COPD exacerbations.

Molinari N, Chanez P, Roche N, Ahmed E, Vachier I, Bourdin A.

Respir Res. 2016 Nov 14;17(1):149.

34.

Adherence to guidelines in idiopathic pulmonary fibrosis: a follow-up national survey.

Cottin V, Bergot E, Bourdin A, Cadranel J, Camus P, Crestani B, Dalphin JC, Delaval P, Dromer C, Israel-Biet D, Kessler R, Marchand-Adam S, Marquette CH, Prévot G, Reynaud-Gaubert M, Valeyre D, Wallaert B, Bouquillon B, Cordier JF.

ERJ Open Res. 2015 Nov 16;1(2). pii: 00032-2015. eCollection 2015 Oct.

35.

High IFN-γ Release and Impaired Capacity of Multi-Cytokine Secretion in IGRA Supernatants Are Associated with Active Tuberculosis.

Carrère-Kremer S, Rubbo PA, Pisoni A, Bendriss S, Marin G, Peries M, Bolloré K, Terru D, Godreuil S, Bourdin A, Van de Perre P, Tuaillon E.

PLoS One. 2016 Sep 7;11(9):e0162137. doi: 10.1371/journal.pone.0162137. eCollection 2016.

36.

CCSP G38A polymorphism environment interactions regulate CCSP levels differentially in COPD.

Knabe L, Varilh J, Bergougnoux A, Gamez AS, Bonini J, Pommier A, Petit A, Molinari N, Vachier I, Taulan-Cadars M, Bourdin A.

Am J Physiol Lung Cell Mol Physiol. 2016 Oct 1;311(4):L696-L703. doi: 10.1152/ajplung.00280.2016. Epub 2016 Aug 5.

37.

[Biomarkers in asthma].

Taillé C, Bourdin A, Garcia G.

Presse Med. 2016 Nov;45(11):1019-1029. doi: 10.1016/j.lpm.2016.04.021. Epub 2016 May 25. Review. French.

PMID:
27236617
38.

[Adaptive servo-ventilation after the SERVE-HF study: The swan song?].

Jaffuel D, Mallet JP, Combes N, Palot A, Rabec C, Molinari N, Jaber S, Bourdin A.

Rev Mal Respir. 2016 Sep;33(7):641-4. doi: 10.1016/j.rmr.2016.04.001. Epub 2016 May 5. French. No abstract available.

PMID:
27155898
39.

Updated guidelines (2015) for management and monitoring of adult and adolescent asthmatic patients (from 12 years and older) of the Société de Pneumologie de Langue Française (SPLF) (Full length text).

Raherison C, Bourdin A, Bonniaud P, Deslée G, Garcia G, Leroyer C, Taillé C, De Blic J, Dubus JC, Tillié-Leblond I, Chanez P.

Rev Mal Respir. 2016 Apr;33(4):279-325. doi: 10.1016/j.rmr.2016.03.002. Epub 2016 Apr 14. No abstract available.

PMID:
27147308
40.

Switching Patients to Home-Based Subcutaneous Immunoglobulin: an Economic Evaluation of an Interprofessional Drug Therapy Management Program.

Perraudin C, Bourdin A, Spertini F, Berger J, Bugnon O.

J Clin Immunol. 2016 Jul;36(5):502-10. doi: 10.1007/s10875-016-0288-z. Epub 2016 May 2.

PMID:
27139500
41.

Updated guidelines (2015) for management and monitoring of adult and adolescent asthmatic patients (from 12 years and older) of the Société de pneumologie de langue française (SPLF) (summary).

Raherison C, Bourdin A, Bonniaud P, Deslée G, Garcia G, Leroyer C, Taillé C, De Blic J, Dubus JC, Tillié-Leblond I, Chanez P.

Rev Mal Respir. 2016 Apr;33(4):271-8. doi: 10.1016/j.rmr.2016.03.001. Epub 2016 Apr 23. No abstract available.

PMID:
27117926
42.

Treatment response with mepolizumab in severe eosinophilic asthma patients with previous omalizumab treatment.

Magnan A, Bourdin A, Prazma CM, Albers FC, Price RG, Yancey SW, Ortega H.

Allergy. 2016 Sep;71(9):1335-44. doi: 10.1111/all.12914. Epub 2016 May 24.

43.

Initial dual oral combination therapy in pulmonary arterial hypertension.

Sitbon O, Sattler C, Bertoletti L, Savale L, Cottin V, Jaïs X, De Groote P, Chaouat A, Chabannes C, Bergot E, Bouvaist H, Dauphin C, Bourdin A, Bauer F, Montani D, Humbert M, Simonneau G.

Eur Respir J. 2016 Jun;47(6):1727-36. doi: 10.1183/13993003.02043-2015. Epub 2016 Mar 17.

44.

Future treatment for asthma.

Charriot J, Vachier I, Halimi L, Gamez AS, Boissin C, Salama M, Cucu-Jarjour A, Ahmed E, Bourdin A.

Eur Respir Rev. 2016 Mar;25(139):77-92. doi: 10.1183/16000617.0069-2015.

45.

Interdisciplinary Medication Adherence Program: The Example of a University Community Pharmacy in Switzerland.

Lelubre M, Kamal S, Genre N, Celio J, Gorgerat S, Hugentobler Hampai D, Bourdin A, Berger J, Bugnon O, Schneider M.

Biomed Res Int. 2015;2015:103546. doi: 10.1155/2015/103546. Epub 2016 Jan 10.

46.

Lung Volume Reduction Coil Treatment vs Usual Care in Patients With Severe Emphysema: The REVOLENS Randomized Clinical Trial.

Deslée G, Mal H, Dutau H, Bourdin A, Vergnon JM, Pison C, Kessler R, Jounieaux V, Thiberville L, Leroy S, Marceau A, Laroumagne S, Mallet JP, Dukic S, Barbe C, Bulsei J, Jolly D, Durand-Zaleski I, Marquette CH; REVOLENS Study Group.

JAMA. 2016 Jan 12;315(2):175-84. doi: 10.1001/jama.2015.17821.

PMID:
26757466
47.

Reply: Increased Mortality during Bleomycin-induced Pulmonary Fibrosis due to Low Endogenous Activated Protein C Levels.

Alagha K, Bourdin A, Chanez P.

Am J Respir Crit Care Med. 2015 Nov 15;192(10):1259-60. doi: 10.1164/rccm.201507-1307LE. No abstract available.

PMID:
26568246
48.

Hospitalizations for COPD Exacerbations: Trends and Determinants of Death.

Molinari N, Briand C, Vachier I, Malafaye N, Aubas P, Georgescu V, Roche N, Chanez P, Bourdin A.

COPD. 2015;12(6):621-7. doi: 10.3109/15412555.2015.1007931. Epub 2015 Aug 11.

PMID:
26263032
49.

Chest Wall Vasculopathy in a Patient with Type 1 Neurofibromatosis.

Bommart S, Bourdin A, Solovei L, Canaud L, Kovacsik H.

Am J Respir Crit Care Med. 2015 Aug 1;192(3):e42-3. doi: 10.1164/rccm.201502-0229IM. No abstract available.

PMID:
26230246
50.

External Validity of Randomized Controlled Trials in Severe Asthma.

Pahus L, Alagha K, Sofalvi T, Vachier I, Bourdin A, Molinari N, Chanez P; COBRA consortium.

Am J Respir Crit Care Med. 2015 Jul 15;192(2):259-61. doi: 10.1164/rccm.201502-0391LE. No abstract available.

PMID:
26177176

Supplemental Content

Loading ...
Support Center